These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27405335)

  • 1. HP-β-cyclodextrin as an inhibitor of amyloid-β aggregation and toxicity.
    Ren B; Jiang B; Hu R; Zhang M; Chen H; Ma J; Sun Y; Jia L; Zheng J
    Phys Chem Chem Phys; 2016 Jul; 18(30):20476-85. PubMed ID: 27405335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides.
    Ren B; Liu Y; Zhang Y; Cai Y; Gong X; Chang Y; Xu L; Zheng J
    ACS Chem Neurosci; 2018 May; 9(5):1215-1224. PubMed ID: 29432676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
    Sun Y; Qian Z; Wei G
    Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
    Shuaib S; Goyal B
    J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NABi, a novel β-sheet breaker, inhibits Aβ aggregation and neuronal toxicity: Therapeutic implications for Alzheimer's disease.
    Jang JY; Rhim H; Kang S
    Biochim Biophys Acta Gen Subj; 2018 Jan; 1862(1):71-80. PubMed ID: 29107146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
    Andarzi Gargari S; Barzegar A; Tarinejad A
    PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ac-LVFFARK-NH
    Zhang H; Dong X; Liu F; Zheng J; Sun Y
    Biophys Chem; 2018 Apr; 235():40-47. PubMed ID: 29453052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyrin Cyclodextrin Conjugates Modulate Amyloid Beta Peptide Aggregation and Cytotoxicity.
    Oliveri V; Zimbone S; Giuffrida ML; Bellia F; Tomasello MF; Vecchio G
    Chemistry; 2018 Apr; 24(24):6349-6353. PubMed ID: 29624764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
    Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
    Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amyloid-selective Photooxygenation toward Treatment for Amyloid Diseases].
    Taniguchi A
    Yakugaku Zasshi; 2018; 138(1):47-53. PubMed ID: 29311465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Mechanism of Inhibition of Au Nanoparticles on the Aggregation of Amyloid-β(16-22) Peptides at the Atom Level by All-Atom Molecular Dynamics.
    Song M; Sun Y; Luo Y; Zhu Y; Liu Y; Li H
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
    Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
    Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease.
    Yao J; Ho D; Calingasan NY; Pipalia NH; Lin MT; Beal MF
    J Exp Med; 2012 Dec; 209(13):2501-13. PubMed ID: 23209315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
    Arai T; Sasaki D; Araya T; Sato T; Sohma Y; Kanai M
    Chembiochem; 2014 Nov; 15(17):2577-83. PubMed ID: 25262917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R; Araya T; Arai T; Sohma Y; Kanai M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease.
    Sun J; Wei C; Liu Y; Xie W; Xu M; Zhou H; Liu J
    Biomaterials; 2019 Mar; 197():417-431. PubMed ID: 30638753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.